alexa Vaccine for Japanese Encephalitis among Travellers

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Vaccine for Japanese Encephalitis among Travellers

A Vero cell-derived, inactivated and alum-adjuvanted JE vaccine based on the SA 14-14-2 strain was approved in 2009 in North America, Australia and various European countries. The primary two doses are administered 4 weeks apart. A booster dose is recommended 1–2 years after the primary immunization. This vaccine has been given concomitantly with hepatitis A vaccine without significant interference with the safety and immunogenicity of either vaccine. Data on concomitant administration with other vaccines frequently used in travellers are currently unavailable.

 
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
 
adwords